Technology News and Research

RSS

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.

5 Oct 2013

'Personalised medicine': Topic of free public lecture at the University of Greenwich

'Personalised medicine' is the topic of a free public lecture at the University of Greenwich. Personalised medicine, or precision medicine, as it is sometimes known, is a key goal for 21st century healthcare. Currently, many medicines are either ineffective or unsafe in certain patient populations, whereas the aim for personalised medicine is to target the right treatment to the right patient group.

5 Oct 2013

Researchers receive prestigious European Health Award for project on new psychoactive drugs

The prestigious European Health Award 2013 has been awarded to Dr Ornella Corazza for the Recreational Drugs European Network (ReDNet), a collaborative prevention project on new psychoactive drugs led by University of Hertfordshire researchers Professor Fabrizio Schifano and Dr Corazza.

5 Oct 2013

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Researchers from the FEMSA Center of Biotechnology at Technologic of Monterrey (ITESM) designed a technology that uses grated carrot to obtain phenolic compounds that have a potential to prevent cancer, and cardiovascular and neurodegenerative diseases.

5 Oct 2013

Using Botox as weight loss tool in rats

Researchers from the Norwegian University of Science and Technology have had promising experimental results from using Botox as a weight loss tool in rats. The research group hopes to win approval for human testing in the near future.

5 Oct 2013

ABC50plus launches new and user-friendly website

ABC50plus, a company that offers quality software solutions for aged care facilities, retirement villages and those in the 50 and up age group, has just announced the launch of its new and user-friendly website.

5 Oct 2013

Merck Canada Awards $15.5M To Four Universities

...

4 Oct 2013

Designer Baby Patent Awarded To 23Andme

...

4 Oct 2013

BioTek’s cell imaging multi-mode reader wins New Product Innovation Award

BioTek’s Cytation™3 Cell Imaging Multi-Mode Reader was recently honored with the first annual New Product Innovation Award, given by MipTec organizers at the 2013 MipTec Conference & Exhibition in Basel, Switzerland. Cytation3 was one of three winning products announced at the exhibition on September 25, 2013.

4 Oct 2013

Eppendorf Sponsoring Shared Lab Space At Cambridge, MA

Eppendorf North America is now a sponsor of LabCentral, a shared laboratory space designed to be a catalyst for entrepreneurs and life science startups. The 27,000 square-foot facility is slated for opening November 1, 2013, and will be located at Kendall Square, Cambridge, MA, in the Cambridge Biotech Innovation Hub.

From Eppendorf 4 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

Kavli Foundation endows new institute at UC Berkeley

The Kavli Foundation has endowed a new institute at the University of California, Berkeley, and the Lawrence Berkeley National Laboratory (Berkeley Lab) to explore the basic science of how to capture and channel energy on the molecular or nanoscale, with the potential for discovering new ways of generating energy for human use.

4 Oct 2013

Cynvenio launches ClearID Breast Cancer monitoring program

Cynvenio, a cancer diagnostics company focused on transforming cancer treatment and management through the molecular analysis of tumor biomarkers in blood, today launched a new weapon in the fight against breast cancer, the ClearID Breast Cancer monitoring program.

4 Oct 2013

Individuals diagnosed with ASD more likely to have gene deletions, shows analysis

Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with autism spectrum disorder (ASD) were more likely to have gene deletions than were people without the disorder.

4 Oct 2013

States seek ways to address marketplace trouble spots; also report progress

News outlets report on the fits and starts of state online health insurance marketplaces in Maryland, New York, Kentucky, Minnesota, Texas, Florida, California and Colorado -- just to name a few.

4 Oct 2013

PhotoMedex introduces NEOVA's hyper-active moisturizer, DNA Barrier Accelerator

PhotoMedex, the leader in photodamage repair technology, clinical skincare and medical laser products for more than a decade, introduces NEOVA® SmartSkinCare brand's DNA Barrier Accelerator, a hyper-active moisturizer that rehabilitates and fortifies the skin's essential protective barrier. DNA Barrier Accelerator is available for purchase in dermatology offices nationwide and on NEOVA.com.

4 Oct 2013

Harvard University receives $3.5M grant to develop super-resolution microscopy technique

A team at the Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded a special $3.5 million grant from the National Institutes of Health (NIH) to develop an inexpensive and easy-to-use new microscopy method to simultaneously spot many tiny components of cells.

4 Oct 2013

J&J's Janssen Companies Launch A Trio Of Collaborations

...

3 Oct 2013

State highlights: L.A. sues to stop measured aimed at creating its own health department; as nation implements health law, Mass. eyes lowering costs

Los Angeles County filed suit Tuesday to remove from the ballot a measure that would strip the city of Los Angeles from the county health department's jurisdiction and require the city to create its own department. The suit argues that the ballot measure, set to appear before voters in June, is invalid because it seeks to take away administrative decision-making authority that is the purview of the county and the city, and that it is preempted by state law (Mehta, 10/1).

3 Oct 2013

CureVac collaborates with Janssen on development of influenza vaccine based on mRNA

CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.

3 Oct 2013

Technology News and Research

New biomarker for pancreatic cancer effectively targets potential therapy for small survival rate

'Personalised medicine': Topic of free public lecture at the University of Greenwich

Researchers receive prestigious European Health Award for project on new psychoactive drugs

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Using Botox as weight loss tool in rats

ABC50plus launches new and user-friendly website

Merck Canada Awards $15.5M To Four Universities

Designer Baby Patent Awarded To 23Andme

BioTek’s cell imaging multi-mode reader wins New Product Innovation Award

Eppendorf Sponsoring Shared Lab Space At Cambridge, MA

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

Kavli Foundation endows new institute at UC Berkeley

Cynvenio launches ClearID Breast Cancer monitoring program

Individuals diagnosed with ASD more likely to have gene deletions, shows analysis

States seek ways to address marketplace trouble spots; also report progress

PhotoMedex introduces NEOVA's hyper-active moisturizer, DNA Barrier Accelerator

Harvard University receives $3.5M grant to develop super-resolution microscopy technique

J&J's Janssen Companies Launch A Trio Of Collaborations

State highlights: L.A. sues to stop measured aimed at creating its own health department; as nation implements health law, Mass. eyes lowering costs

CureVac collaborates with Janssen on development of influenza vaccine based on mRNA

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News